Amedisys Financial Statements From 2010 to 2024

AMED Stock  USD 93.61  0.08  0.09%   
Amedisys financial statements provide useful quarterly and yearly information to potential Amedisys investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Amedisys financial statements helps investors assess Amedisys' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Amedisys' valuation are summarized below:
Gross Profit
454 M
Profit Margin
0.0012
Market Capitalization
3.1 B
Enterprise Value Revenue
1.5567
Revenue
2.2 B
There are over one hundred two available fundamental signals for Amedisys, which can be analyzed over time and compared to other ratios. Investors should ensure to validate all of Amedisys' prevailing performance against the performance from 2010 to 2024 to make sure the company is sustainable down the road. At present, Amedisys' Enterprise Value is projected to increase significantly based on the last few years of reporting. The current year's Free Cash Flow is expected to grow to about 148.6 M, whereas Average Assets are forecasted to decline to about 1.8 B.

Amedisys Revenues

2.32 Billion

Check Amedisys financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amedisys main balance sheet or income statement drivers, such as Direct Expenses of 990.1 M, Consolidated Income of 114.2 M or Cost of Revenue of 1.3 B, as well as many exotic indicators such as Interest Coverage of 10.52, Long Term Debt to Equity of 0.28 or Calculated Tax Rate of 35.72. Amedisys financial statements analysis is a perfect complement when working with Amedisys Valuation or Volatility modules.
  
This module can also supplement Amedisys' financial leverage analysis and stock options assessment as well as various Amedisys Technical models . Check out the analysis of Amedisys Correlation against competitors.
For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.

Amedisys Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Tax Liabilities19 M23.5 M14.5 M
Slightly volatile
Tax Assets266.9 K260.1 K73.5 M
Slightly volatile
Accumulated Retained Earnings Deficit940.1 M871.3 M235.4 M
Slightly volatile
Trade and Non Trade Receivables292.9 M341.3 M194.9 M
Slightly volatile
Property Plant and Equipment Net124.4 M136.7 M109.6 M
Pretty Stable
Trade and Non Trade Payables44 M50.3 M30.4 M
Slightly volatile
Liabilities Non Current637.9 M591.3 M226.8 M
Slightly volatile
Current Liabilities376.2 M408.9 M300.3 M
Slightly volatile
Total Liabilities806 MB513.2 M
Slightly volatile
Goodwill and Intangible Assets1.7 B1.6 B689.9 M
Slightly volatile
Shareholders Equity USD987.8 M1.2 B625.5 M
Slightly volatile
Shareholders Equity Attributable to Parent987.8 M1.2 B625.5 M
Slightly volatile
Total Debt USD667.5 M618.6 M239.5 M
Slightly volatile
Debt Non Current606.7 M562.3 M214.3 M
Slightly volatile
Debt Current60.8 M56.4 M25.3 M
Slightly volatile
Total Debt667.5 M618.6 M239.5 M
Slightly volatile
Cash and Equivalents USD59.9 M62.3 M42.9 M
Slightly volatile
Cash and Equivalents59.9 M62.3 M42.9 M
Slightly volatile
Assets Non CurrentB1.8 B909.3 M
Slightly volatile
Current Assets393.2 M447.3 M278.7 M
Slightly volatile
Total Assets1.8 B2.3 B1.2 B
Slightly volatile
Accumulated Other Comprehensive Income13.4 K13.5 K14.8 K
Slightly volatile
Accounts Payable33 M39.4 M30.2 M
Slightly volatile
Receivables218.8 M267.1 M193.4 M
Slightly volatile

Amedisys Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Income Tax Expense39.9 M48.9 M10.5 M
Slightly volatile
Weighted Shares Diluted38.9 M37.6 M33.4 M
Slightly volatile
Weighted Shares38.6 M37.4 M33.1 M
Slightly volatile
Selling General and Administrative Expense518.2 M585.1 M376.2 M
Slightly volatile
Revenues USD2.3 B2.6 B1.7 B
Slightly volatile
Revenues2.3 B2.6 B1.7 B
Slightly volatile
Operating Income166.2 M207.9 M59.3 M
Slightly volatile
Operating Expenses827.4 M899.3 M660.2 M
Slightly volatile
Net Income to Non Controlling Interests(1.1 M)(1 M)(207.8 K)
Slightly volatile
Net Loss Income from Discontinued Operations199.5 K194.4 K975.3 K
Slightly volatile
Net Income Common Stock USD114.6 M136.4 M46.7 M
Slightly volatile
Net Income Common Stock114.6 M136.4 M46.7 M
Slightly volatile
Net Income114.6 M136.4 M46.7 M
Slightly volatile
Interest Expense27.6 M25.6 M11 M
Slightly volatile
Gross Profit993.6 M1.1 B719.5 M
Slightly volatile
Earning Before Interest and Taxes USD173.6 M210.9 M67.6 M
Slightly volatile
Earning Before Interest and Taxes EBIT173.6 M210.9 M67.6 M
Slightly volatile
Cost of Revenue1.3 B1.4 B974.8 M
Slightly volatile
Consolidated Income114.2 M135.4 M46.6 M
Slightly volatile
Direct Expenses990.1 M1.1 B950.6 M
Slightly volatile

Amedisys Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Share Based Compensation19.7 M19 M15 M
Slightly volatile
Net Cash Flow from Operations158.8 M153.3 M131.2 M
Slightly volatile
Net Cash Flow Investment Acquisitions and Disposals(18.5 M)(18 M)(6.3 M)
Very volatile
Net Cash Flow from Financing(35.9 M)(35 M)(18.5 M)
Pretty Stable
Issuance Repayment of Debt Securities (15.7 M)(15.3 M)7.3 M
Slightly volatile
Issuance Purchase of Equity Shares(10.9 M)(10.1 M)(18 M)
Pretty Stable
Net Cash Flow Business Acquisitions and Disposals(69.9 M)(64.8 M)(83.3 M)
Slightly volatile
Net Cash Flow or Change in Cash and Cash Equivalents8.1 M7.5 M4.2 M
Very volatile
Depreciation Amortization and Accretion66.1 M81.6 M44 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Tangible Assets Book Value per Share19.3220.7815.4025
Slightly volatile
Sales per Share71.278.6352.3199
Slightly volatile
Return on Sales0.08020.09430.0228
Slightly volatile
Return on Invested Capital0.310.30.0972
Slightly volatile
Return on Equity0.130.140.0401
Slightly volatile
Return on Assets0.06690.0690.0177
Slightly volatile
Price to Sales Ratio1.761.411.4589
Slightly volatile
Price to Earnings Ratio28.426.32(3.6468)
Pretty Stable
Price to Book Value4.452.974.0741
Slightly volatile
Profit Margin0.05240.06090.0156
Slightly volatile
Gross Margin0.510.50.4332
Slightly volatile
Free Cash Flow per Share4.564.53.5317
Slightly volatile
Enterprise Value over EBITDA19.5214.6714.9797
Slightly volatile
Enterprise Value over EBIT23.5216.225.7811
Pretty Stable
Earnings per Basic Share USD3.524.21.4004
Slightly volatile
Earnings per Diluted Share3.474.171.3656
Slightly volatile
Earnings per Basic Share3.524.21.4004
Slightly volatile
EBITDA Margin0.110.130.0482
Slightly volatile
Debt to Equity Ratio0.940.950.8251
Very volatile
Current Ratio1.241.260.9677
Slightly volatile
Book Value per Share30.3537.1919.2916
Slightly volatile
Asset Turnover1.241.021.6171
Slightly volatile
Total Assets Per Share59.0254.736.3747
Slightly volatile
Cash Flow Per Share3.733.694.1807
Pretty Stable
Return on Investment12.2611.375.1095
Slightly volatile
Operating Margin7.897.322.249
Slightly volatile
Calculated Tax Rate35.7230.5236.1685
Slightly volatile
Receivables Turnover10.198.949.481
Slightly volatile
PPandE Turnover12511655.027
Slightly volatile
Cash and Equivalents Turnover46.1348.0849.1437
Very volatile
Accounts Payable Turnover67.3362.3960.2754
Pretty Stable
Accrued Expenses Turnover9.899.228.8161
Pretty Stable
Interest Coverage10.527.3811.9879
Pretty Stable
Long Term Debt to Equity0.280.360.2392
Slightly volatile
Quick Ratio0.80.830.8575
Very volatile
Net Current Assets as percentage of Total Assets1.641.520.3294
Very volatile
Revenue to Assets1.651.291.6474
Slightly volatile

Amedisys Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Working Capital41.5 M38.4 M(19.9 M)
Slightly volatile
Tangible Asset Value628.6 M675.8 M497.4 M
Slightly volatile
Market Capitalization3.5 B3.1 B2.7 B
Slightly volatile
Invested Capital Average651.6 M820.2 M402.5 M
Slightly volatile
Invested Capital888.4 M823.4 M395.6 M
Slightly volatile
Free Cash Flow148.6 M146.3 M114.7 M
Slightly volatile
Enterprise ValueB3.7 B2.9 B
Slightly volatile
Average Equity943.6 M1.2 B609.8 M
Slightly volatile
Earnings before Tax154.5 M185.3 M57.2 M
Slightly volatile
Earnings Before Interest Taxes and Depreciation Amortization USD239.7 M292.5 M111.6 M
Slightly volatile
Earnings Before Interest Taxes and Depreciation Amortization EBITDA239.7 M292.5 M111.6 M
Slightly volatile
Average Assets1.8 B2.3 B1.1 B
Slightly volatile
Revenue Per Employee91.8 K100 K93.4 K
Slightly volatile
Net Income Per Employee5.8 K5.3 K1.6 K
Slightly volatile

Amedisys Fundamental Market Drivers

Forward Price Earnings20.6612
Cash And Short Term Investments40.5 M

Amedisys Upcoming Events

21st of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
21st of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Amedisys Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Amedisys income statement, its balance sheet, and the statement of cash flows. Amedisys investors use historical funamental indicators, such as Amedisys's revenue or net income, to determine how well the company is positioned to perform in the future. Although Amedisys investors may use each financial statement separately, they are all related. The changes in Amedisys's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Amedisys's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Amedisys Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Amedisys. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Cost of Revenue1.4 B1.3 B
Revenues2.6 B2.3 B
Revenue to Assets 1.29  1.65 
Revenue Per Employee100 K91.8 K

Pair Trading with Amedisys

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amedisys position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amedisys will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Amedisys could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amedisys when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amedisys - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amedisys to buy it.
The correlation of Amedisys is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amedisys moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amedisys moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amedisys can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Amedisys is a strong investment it is important to analyze Amedisys' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Amedisys' future performance. For an informed investment choice regarding Amedisys Stock, refer to the following important reports:
Check out the analysis of Amedisys Correlation against competitors.
For information on how to trade Amedisys Stock refer to our How to Trade Amedisys Stock guide.
Note that the Amedisys information on this page should be used as a complementary analysis to other Amedisys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Complementary Tools for Amedisys Stock analysis

When running Amedisys' price analysis, check to measure Amedisys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amedisys is operating at the current time. Most of Amedisys' value examination focuses on studying past and present price action to predict the probability of Amedisys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amedisys' price. Additionally, you may evaluate how the addition of Amedisys to your portfolios can decrease your overall portfolio volatility.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Fundamental Analysis
View fundamental data based on most recent published financial statements
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Is Amedisys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amedisys. If investors know Amedisys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amedisys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.001
Earnings Share
0.08
Revenue Per Share
68.4
Quarterly Revenue Growth
(0)
Return On Assets
0.0604
The market value of Amedisys is measured differently than its book value, which is the value of Amedisys that is recorded on the company's balance sheet. Investors also form their own opinion of Amedisys' value that differs from its market value or its book value, called intrinsic value, which is Amedisys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amedisys' market value can be influenced by many factors that don't directly affect Amedisys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amedisys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amedisys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amedisys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.